Novo Ceo Is Looking at Targets in M&A ‘Hot Space’

The video discusses the pricing and volume challenges in the US market, guidance on sales and business growth, the impact of currency fluctuations, and strategies for acquisitions and market competition. It highlights the focus on innovation and long-term growth, positioning against competition in the diabetes market, and the potential impact of gene therapy.

What factors are influencing the pricing picture in the United States for 2018?

How did the company perform in the diabetes and obesity market in the first half of the year?

What is the company's approach to managing currency fluctuations?

What are the company's plans regarding bolt-on acquisitions?

How does the company view the potential impact of gene therapy on its business?